ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

ClinicalTrials.gov ID: NCT05330325

Public ClinicalTrials.gov record NCT05330325. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 9:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study Comparing the Effect and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® as Well as Evaluating Long-term Safety of Somapacitan in a Basket Study Design in Children With Short Stature Either Born Small for Gestational Age or With Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

Study identification

NCT ID
NCT05330325
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
412 participants

Conditions and interventions

Interventions

  • Norditropin® Drug
  • Somapacitan Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 10 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 9, 2022
Primary completion
Aug 4, 2024
Completion
Oct 28, 2027
Last update posted
Apr 23, 2026

2022 – 2027

United States locations

U.S. sites
35
U.S. states
24
U.S. cities
35
Facility City State ZIP Site status
Univ of AL at Birmingham_BRM Birmingham Alabama 35233
Children's Hospital Los Angeles - Endocrinology Los Angeles California 90027
Sutter Valley Med Fdt Ped Endo Sacramento California 95821
Rady Childrens Hosp San Diego San Diego California 92123
Children's Hospital Colorado Aurora Colorado 80045
Rocky Mt Ped and Endo Centennial Colorado 80112
Ped Endo Assoc PC-G.V Greenwood Village Colorado 80111-2803
Nemours/AI duPont Hosp-Chld Wilmington Delaware 19803
Childrens National Medical Ctr Washington D.C. District of Columbia 20010-2978
Nemours Chld Clnc Jacksonville Jacksonville Florida 32207
Atlanta Diabetes Associates Atlanta Georgia 30318
St. Luke's Children's Endo Boise Idaho 83712
Rocky Mt Clin Res, LLC Idaho Falls Idaho 83404-7596
Riley Hosp for Child-Indiana U Indianapolis Indiana 46202
University OF Iowa Iowa City Iowa 52242
UMass Medical School Worcester Massachusetts 01655
Univ of Minnesota M.C.H. Minneapolis Minnesota 55454
Children's Minnesota Saint Paul Minnesota 55102
Univ of Mississippi Med Ctr Jackson Mississippi 39216
The Children's Mercy Hospital Kansas City Missouri 64108
Goryeb Children's Hospital Morristown New Jersey 07962
UBMD Peds-Div of Endo/Diabetes Buffalo New York 14203
NYU Langone Hospital-LI Garden City New York 11530
NYU Langone Hospital-LI Mineola New York 11501
WakeMed Childn Endo-Dbt_Raleig Raleigh North Carolina 27610
Akron Children's Hospital Akron Ohio 44308
CCHMC_Cinc Cincinnati Ohio 45229
Univ Oklahoma Sci Ctr OK City Oklahoma City Oklahoma 73104
UPMC Child Hosp-Pittsburgh Pittsburgh Pennsylvania 15224
UT Southwestern Med Cntr Dallas Texas 75235
Cook Children's Medical Center Fort Worth Texas 76104
Consano Clinical Research, LLC Shavano Park Texas 78231
University Of Virginia Hospital Charlottesville Virginia 22903
MultiCare Inst for Res & Innov Tacoma Washington 98405
Marshfield Clinic Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 164 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05330325, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05330325 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →